Drug targeting using thermally responsive polymers and local hyperthermia.
暂无分享,去创建一个
M. Dewhirst | A. Chilkoti | G. Kong | M W Dewhirst | D. E. Meyer | B. Shin | A Chilkoti | D E Meyer | G A Kong | B C Shin
[1] G. Rosner,et al. Measurement of material extravasation in microvascular networks using fluorescence video-microscopy. , 1993, Microvascular research.
[2] R. Panchagnula,et al. Monoclonal antibodies in drug targeting , 1997, Journal of clinical pharmacy and therapeutics.
[3] E. Ruoslahti,et al. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. , 1998, Science.
[4] Howard G. Schild,et al. Cononsolvency in mixed aqueous solutions of poly(N-isopropylacrylamide) , 1991 .
[5] B Mattiasson,et al. 'Smart' polymers and what they could do in biotechnology and medicine. , 1999, Trends in biotechnology.
[6] T. M. Parker,et al. Temperature of polypeptide inverse temperature transition depends on mean residue hydrophobicity , 1991 .
[7] T. Samulski,et al. Heating deep seated eccentrically located tumors with an annular phased array system: a comparative clinical study using two annular array operating configurations. , 1987, International journal of radiation oncology, biology, physics.
[8] J. Murgo,et al. Microsphere and dilution techniques for the determination of blood flows and volumes in conscious mice. , 1992, The American journal of physiology.
[9] R K Jain,et al. Barriers to drug delivery in solid tumors. , 1994, Scientific American.
[10] P. Durbin,et al. Gross composition and plasma and extracellular water volumes of tissues of a reference mouse. , 1992, Health physics.
[11] John W. Strohbehn,et al. Experience with a Multitransducer Ultrasound System for Localized Hyperthermia of Deep Tissues , 1984, IEEE Transactions on Biomedical Engineering.
[12] R. Roemer,et al. Oscillatory temperature response to constant power applied to canine muscle. , 1985, The American journal of physiology.
[13] Charles K. Chiklis,et al. Swelling of thin films. I. Acrylamide–N‐isopropylacrylamide copolymers in water , 1970 .
[14] S. Yuk,et al. Phase-transition polymers for drug delivery. , 1999, Critical reviews in therapeutic drug carrier systems.
[15] M. Dewhirst,et al. Hyperthermia and liposomes. , 1999, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[16] H. Fujita. [Anticancer drugs]. , 1995, Nihon rinsho. Japanese journal of clinical medicine.
[17] J. Taillefer,et al. Preparation and characterization of pH-responsive polymeric micelles for the delivery of photosensitizing anticancer drugs. , 2000, Journal of pharmaceutical sciences.
[18] Jindrich Kopecek,et al. Polymerizable Fab′ antibody fragments for targeting of anticancer drugs , 1999, Nature Biotechnology.
[19] Jan Feijen,et al. Effect of comonomer hydrophilicity and ionization on the lower critical solution temperature of N-isopropylacrylamide copolymers , 1993 .
[20] Robert B. Roemer,et al. A uniform thermal field in a hyperthermia chamber for microvascular studies , 1982 .
[21] T. Okano,et al. Thermo-responsive drug delivery from polymeric micelles constructed using block copolymers of poly(N-isopropylacrylamide) and poly(butylmethacrylate). , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[22] F. Waterman,et al. Thermoradiotherapy in the management of superficial malignant tumors. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[23] Purification of recombinant proteins , 1996 .
[24] Howard G. Schild,et al. Microcalorimetric detection of lower critical solution temperatures in aqueous polymer solutions , 1990 .
[25] Jie Xu,et al. Product purification by reversible phase transition following Escherichia coli expression of genes encoding up to 251 repeats of the elastomeric pentapeptide GVGVP. , 1996, Protein expression and purification.
[26] A. Hoffman,et al. Lower critical solution temperatures of aqueous copolymers of N-isopropylacrylamide and other N-substituted acrylamides , 1987 .
[27] Ick Chan Kwon,et al. Saccharide effect on the lower critical solution temperature of thermosensitive polymers , 1995 .
[28] H. G. Schild. Poly(N-isopropylacrylamide): experiment, theory and application , 1992 .
[29] R. Freitag,et al. Investigation of the LCST of polyacrylamides as a function of molecular parameters and the solvent composition , 1999 .
[30] T. Feyerabend,et al. Rationale and clinical status of local hyperthermia, radiation, and chemotherapy in locally advanced malignancies. , 1997, Anticancer research.
[31] S. Badylak,et al. Hyperthermia‐induced vascular injury in normal and neoplastic tissue , 1985, Cancer.
[32] Oscar Chiantore,et al. Solution properties of poly(N‐isopropylacrylamide) , 1979 .
[33] Ashutosh Chilkoti,et al. Purification of recombinant proteins by fusion with thermally-responsive polypeptides , 1999, Nature Biotechnology.
[34] S. B. Field,et al. An Introduction to the Practical Aspects of Clinical Hyperthermia , 1990 .
[35] P. F. Turner,et al. Mini-Annular Phased Array for Limb Hyperthermia , 1986 .
[36] J. Rhee,et al. Implication of Blood Flow in Hyperthermic Treatment of Tumors , 1984, IEEE Transactions on Biomedical Engineering.
[37] M. Gaze. The current status of targeted radiotherapy in clinical practice. , 1996, Physics in medicine and biology.
[38] P. Vaupel,et al. Physiological effects of hyperthermia. , 1987, Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer.
[39] R. Duncan,et al. Drug-polymer conjugates: potential for improved chemotherapy. , 1992, Anti-cancer drugs.
[40] M. Jones,et al. Polymeric micelles - a new generation of colloidal drug carriers. , 1999, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[41] D. Urry,et al. Phase‐structure transitions of the elastin polypentapeptide–water system within the framework of composition–temperature studies , 1985, Biopolymers.
[42] V. Torchilin. Polymer-coated long-circulating microparticulate pharmaceuticals. , 1998, Journal of microencapsulation.
[43] D. Urry. Physical Chemistry of Biological Free Energy Transduction As Demonstrated by Elastic Protein-Based Polymers† , 1997 .
[44] H. Maeda,et al. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. , 1986, Cancer research.
[45] M. Dewhirst,et al. Targeting a genetically engineered elastin-like polypeptide to solid tumors by local hyperthermia. , 2001, Cancer research.
[46] M. Dewhirst,et al. Thermosensitive liposomes: extravasation and release of contents in tumor microvascular networks. , 1996, International journal of radiation oncology, biology, physics.
[47] D. Urry. Free energy transduction in polypeptides and proteins based on inverse temperature transitions. , 1992, Progress in biophysics and molecular biology.
[48] F Liu,et al. Modulating insulin-release profile from pH/thermosensitive polymeric beads through polymer molecular weight. , 1999, Journal of controlled release : official journal of the Controlled Release Society.
[49] Nikolaos A. Peppas,et al. Pulsatile local delivery of thrombolytic and antithrombotic agents using poly(N-isopropylacrylamide-co-methacrylic acid) hydrogels , 1996 .
[50] T. Okano,et al. Pulsatile drug delivery systems using hydrogels , 1993 .
[51] E. Hersh,et al. Phase I trial of recombinant interleukin 3 before and after carboplatin/etoposide chemotherapy in patients with solid tumors: a southwest oncology group study. , 1995, Clinical cancer research : an official journal of the American Association for Cancer Research.
[52] D Needham,et al. Increased microvascular permeability contributes to preferential accumulation of Stealth liposomes in tumor tissue. , 1993, Cancer research.
[53] J F Gross,et al. Morphologic and hemodynamic comparison of tumor and healing normal tissue microvasculature. , 1989, International journal of radiation oncology, biology, physics.
[54] Mark W. Dewhirst,et al. Review Hyperthermia and liposomes , 1999 .
[55] R. Langer,et al. Drug delivery and targeting. , 1998, Nature.
[56] M. Dewhirst. Future directions in hyperthermia biology. , 1994, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.
[57] G. Rosner,et al. Hyperthermic treatment of malignant diseases: current status and a view toward the future. , 1997, Seminars in oncology.
[58] Allan S. Hoffman,et al. “intelligent” polymers in medicine and biotechnology , 1995 .
[59] K. Engin. Biological rationale and clinical experience with hyperthermia. , 1996, Controlled clinical trials.
[60] K Hynynen,et al. Ultrasound technology for hyperthermia. , 1999, Ultrasound in medicine & biology.
[61] R. Issels. Hyperthermia Combined with Chemotherapy – Biological Rationale, Clinical Application, and Treatment Results , 1999, Oncology Research and Treatment.
[62] L. D. Taylor,et al. Preparation of films exhibiting a balanced temperature dependence to permeation by aqueous solutions—a study of lower consolute behavior , 1975 .
[63] Chuan Yi Tang,et al. A 2.|E|-Bit Distributed Algorithm for the Directed Euler Trail Problem , 1993, Inf. Process. Lett..